Lumos Pharma(LUMO) - 2022 Q2 - Earnings Call Presentation
Second Quarter 2022 Financial Results & Clinical Update 1 August 9, 2022 Forward Looking Statements This presentation contains forward-looking statements of Lumos Pharma, Inc. that involve substantial risks and uncertainties. All such statements contained in this presentation are forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995, a law that gives us the opportunity to share our outlook for the future without fear of litigation if it turns out our predictio ...